Daily Mail & General Trust (UK): Distribution of Euromoney Institutional Investor (UK)
06 March 2019
FTSE Russell notes the distribution of shares in Euromoney Institutional Investor (UK, 0688666, FTSE 250 Index) by Daily Mail & General Trust (UK, 0945736, GEIS Small Cap). The distribution of shares will be accompanied by a cash distribution and share reduction in Daily Mail & General Trust. The terms for non-restricted shareholders will be 0.19933 of an Euromoney Institutional Investor share, a reduction of 0.46409 of a share and GBP 0.6812597 for each Daily Mail & General Trust share held.
Subject to shareholder approval(the shareholder meeting is scheduled for 26 March 2019), FTSE Russell anticipates the following treatment:
Monday 01 April 2019 (from the open):
A temporary line representing the shares of Euromoney Institutional Investor distributed to Daily Mail & General Trust holders will be added to Daily Mail & General Trust's Indexes. The close price of the temporary line will be updated daily to align with the close price of Euromoney Institutional Investor.
Daily Mail & General Trust shares will be adjusted based on the share reduction terms; while its price will be adjusted to incorporate the value of the cash distribution, the value of the Euromoney Institutional Investor share distribution, and the share reduction.
Thursday 04 April 2019 (from the open):
After settlement, the temporary line will be removed from all indexes.
Euromoney Institutional Investor will remain in its indexes at an increased weight.
For further information please contact FTSE Russell Client Services at [email protected] or call:
+1800 653 680
+852 2164 3333
+81 3 4563 6346
+44 (0) 20 7866 1810
+1866 551 0617
Alternatively please visit our website at www.ftserussell.com
This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact [email protected] or visit www.rns.com.
Create your account: sign up and get ahead on news and events
NO INVESTMENT ADVICE
The Company is a publisher. You understand and agree that no content published on the Site constitutes a recommendation that any particular security, portfolio of securities, transaction, or investment strategy is...